Tolterodine (ATC code: G04BD) is an antimuscarinic drug that is used to treat urinary incontinence. It is sold under the trade name Detrol.
Tolterodine acts on M2 and M3 subtypes of muscarinic receptors whereas most antimuscarinic treatments for overactive bladder only act on M3 receptors making them more selective. Tolterodine, however, although it acts on two types of receptors, has less side effects than other antimuscarinics eg. oxybutynin (which is selective for M3 only) as tolterodine targets the bladder more than other areas of the body. This means that less drug needs to be given daily (due to efficient targeting of the bladder) and so there are less side effects eg. hyposalivation, constipation, decreased gastric motility.

Detrol - Manufacturer's information about this medication for people with bladder control problems. Includes information on diagnosis and treatment with Detrol (tolterodine).
Meta Description: [ Learn about the causes and symptoms of overactive bladder (OAB), and how you can help treat it. ]
404
Detrol (Tolterodine tartrate) - An incontinence product by Pharmacia and Upjohn.
Food and Drug Administration (FDA) - Detrol Consumer Information - Patient FAQ in html format with a link to approved labeling (as pdf).
Meta Description: [ Consumer Information Sheet ]
| The 13-metal medal - Periodic Table of Videos | |
| Next Video | |